Trade Aytu BioScience, Inc. - AYTU CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.062 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.664 |
| Open | 1.624 |
| 1-Year Change | -41.07% |
| Day's Range | 1.624 - 1.664 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 24, 2025 | 1.664 | 0.040 | 2.46% | 1.624 | 1.694 | 1.594 |
| Jan 23, 2025 | 1.654 | -0.030 | -1.78% | 1.684 | 1.694 | 1.614 |
| Jan 22, 2025 | 1.694 | 0.030 | 1.80% | 1.664 | 1.754 | 1.664 |
| Jan 21, 2025 | 1.694 | 0.000 | 0.00% | 1.694 | 1.774 | 1.644 |
| Jan 17, 2025 | 1.684 | -0.110 | -6.13% | 1.794 | 1.814 | 1.674 |
| Jan 16, 2025 | 1.714 | 0.120 | 7.53% | 1.594 | 1.714 | 1.594 |
| Jan 15, 2025 | 1.594 | 0.010 | 0.63% | 1.584 | 1.624 | 1.544 |
| Jan 14, 2025 | 1.604 | -0.020 | -1.23% | 1.624 | 1.634 | 1.574 |
| Jan 13, 2025 | 1.634 | 0.030 | 1.87% | 1.604 | 1.654 | 1.574 |
| Jan 10, 2025 | 1.694 | 0.060 | 3.67% | 1.634 | 1.734 | 1.604 |
| Jan 8, 2025 | 1.714 | 0.000 | 0.00% | 1.714 | 1.774 | 1.664 |
| Jan 7, 2025 | 1.694 | -0.110 | -6.10% | 1.804 | 1.814 | 1.664 |
| Jan 6, 2025 | 1.824 | 0.090 | 5.19% | 1.734 | 1.834 | 1.674 |
| Jan 3, 2025 | 1.744 | 0.080 | 4.81% | 1.664 | 1.764 | 1.664 |
| Jan 2, 2025 | 1.654 | 0.010 | 0.61% | 1.644 | 1.704 | 1.634 |
| Dec 31, 2024 | 1.644 | 0.110 | 7.17% | 1.534 | 1.684 | 1.534 |
| Dec 30, 2024 | 1.574 | 0.170 | 12.11% | 1.404 | 1.594 | 1.394 |
| Dec 27, 2024 | 1.484 | -0.040 | -2.62% | 1.524 | 1.524 | 1.394 |
| Dec 26, 2024 | 1.504 | 0.010 | 0.67% | 1.494 | 1.534 | 1.434 |
| Dec 24, 2024 | 1.454 | 0.050 | 3.56% | 1.404 | 1.484 | 1.404 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Aytu BioScience, Inc. Company profile
About Aytu Biopharma Inc
Aytu Biopharma, Inc., formerly Aytu BioScience, Inc., is a specialty pharmaceutical company. The Company markets a portfolio of prescription products addressing primary care and pediatric markets. The Company's primary prescription products treat attention deficit hyperactivity disorder (ADHD) and other common pediatric conditions. It markets ADHD products Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets, Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets, and Adzenys-ER (amphetamine) extended-release oral suspension. The Company's other pediatric products include Karbinal ER (carbinoxamine maleate), an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary fluoride-based prescription vitamin product lines containing combinations of fluoride and vitamins in formulations for infants and children with fluoride deficiency.
Financial summary
BRIEF: For the six months ended 31 December 2021, Aytu Biopharma Inc revenues increased 57% to $45M. Net loss increased from $13.8M to $39.4M. Revenues reflect United States segment increase of 69% to $43.7M. Basic Earnings per Share excluding Extraordinary Items decreased from -$1.07 to -$1.53.
Equity composition
Common Stock no Par, 11/11, 30M auth., 4,774,568 issd. Insiders own 66.98%. 06/15, 1-for-12.174, Reverse Stock Split.
| Industry: | Pharmaceuticals (NEC) |
7900 E. Union Avenue
Suite 920
DENVER
COLORADO 80237
US
News
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com